Related Experiment Video
Updated: Jul 6, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
The obesity epidemic: pharmacological challenges
Stephen R Bloom1, Francis P Kuhajda, Ismail Laher
1Hammersmith Hospital, Imperial College , London, UK W120NN.
Molecular Interventions
|April 12, 2008
Summary
Obesity, a serious health issue, affects over 30% of adults and 15% of children, increasing risks for diabetes and heart disease. Effective therapeutic interventions are urgently needed to combat this growing epidemic.
Area of Science:
- Public Health
- Epidemiology
- Metabolic Disorders
Background:
- Obesity, defined as a body mass index (BMI) over 30kg/m(2), is a growing global health crisis.
- Complex factors contribute to the obesity epidemic, including modern dietary habits, sedentary lifestyles, and genetic predispositions (thrifty-gene theory).
- Current estimates indicate over 30% of adults and 15% of juveniles are obese, leading to significant health burdens.
Purpose of the Study:
- To highlight the escalating crisis of obesity and its profound impact on public health.
- To underscore the urgent need for effective therapeutic interventions and strategies to combat obesity.
- To provide an overview of the multifactorial origins of the obesity epidemic.
Main Methods:
- Review of epidemiological data on obesity prevalence.
- Analysis of contributing factors, including lifestyle, environmental, and genetic elements.
- Examination of associated comorbidities and health consequences.
Main Results:
- Obesity prevalence exceeds 30% in adults and 15% in juveniles.
- Obesity is linked to increased incidence of type 2 diabetes, cardiovascular diseases, respiratory issues, depression, and certain cancers.
- The multifactorial nature of obesity necessitates a comprehensive approach to management.
Conclusions:
- Obesity represents a critical public health challenge with severe health implications.
- Addressing obesity requires multifaceted interventions targeting diet, physical activity, and potentially genetic factors.
- Further research and public health initiatives are essential to mitigate the impact of obesity.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...